Koyfin Home > Directory > Health Care > Akebia Therapeutics > Cash Acquisitions

Akebia Therapeutics Cash Acquisitions Chart (AKBA)

Akebia Therapeutics annual/quarterly Cash Acquisitions from 2018 to 2018.
  • Akebia Therapeutics Cash Acquisitions for the quarter ending December 12, 2018 was $6m
  • Akebia Therapeutics Cash Acquisitions for the last 12 months ending September 09, 2019 was $6m a 0.00% decrease of 0m year over year
Other Cash Flow Metrics:
  • Akebia Therapeutics Cash Flow from Operations for the quarter ending December 12, 2018 was $-74m a 72.41% decrease of -53m year over year
  • Akebia Therapeutics Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-92m a 89.67% decrease of -82m year over year
  • Akebia Therapeutics Total Revenue for the quarter ending December 12, 2018 was $60m a 23.26% increase of 14m year over year
View Chart On Koyfin

Quarterly AKBA Cash Acquisitions Data

12/2018$6m

Annual AKBA Cash Acquisitions Data

2018$6m